Skip to main content
SpringerLink
Log in

Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience

  • Urology – Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objective

To demonstrate the efficacy of hormone treatment on the patients with hypogonadotropic hypogonadism (HH), we summarized our more than 10 years experience.

Materials and methods

A total of 242 male patients (age range 15–52 years old) with HH including two Kallmann syndrome treated at the andrology outpatient clinics of university hospital in the past 10 years were reviewed retrospectively. The patients were divided into three groups based on the different treatment strategy. There were 84 patients treated with human chorionic gonadotropin (hCG) (group 1, hCG treatment group), 74 patients treated with hCG plus human menopause gonadotropin (hMG) (group 2, hCG + hMG treatment group), and 84 patients treated with testosterone (group 3, T treatment group). Sex characteristics, testicular volume, and sperm production were determined before and after the treatments. The therapeutic effects in the three groups were analyzed statistically.

Results

In total, 42 patients of group 1 (50.0%) and 56 of group 2 (75.7%) had their testicular volumes increased after 6–18 months treatment, from 2.0 ± 1.1 to 6.8 ± 3.2 mL and 2.1 ± 1.1 to 8.8 ± 3.9 mL, respectively. Only six patients of group 3 had their testicular volumes increased but no statistically significant. Among the patients with testes growth, 34 patients of group 1 and 48 patients of group 2 achieved spermatogenesis, and three of them made their wives pregnant naturally. During the follow-up after treatment, there were 36 patients finally defined as delayed puberty, and 204 patients defined as idiopathic hypogonadotropic hypogonadism.

Conclusions

For the hormonal treatment of HH, testosterone therapy could not stimulate testes growth and spermatogenesis, but HCG therapy and hCG/hMG combination therapy both are effective, while hCG/hMG combination therapy could achieve better therapeutic effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zitzmann M, Nieschlag E (2000) Hormone substitution in male hypogonadism. Mol Cell Endocrinol 161:73–88

    Article  PubMed  CAS  Google Scholar 

  2. Burris AS, Rodbard HW, Winters SJ, Sherins RJ (1988) Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol Metab 66:1144–1151

    Article  PubMed  CAS  Google Scholar 

  3. Vicari E, Mongioi A, Calogero AE, Moncada ML, Sidoti G, Polosa P, D’Agata R (1992) Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism–long-term follow-up. Int J Androl 15:320–329

    Article  PubMed  CAS  Google Scholar 

  4. Miyagawa Y, Tsujimura A, Matsumiya K, Takao T, Tohda A, Koga M, Takeyama M, Fujioka (2005) Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study. J Urol 173:2072–2075

    Article  PubMed  CAS  Google Scholar 

  5. Homayoun A, Asghar D, Darab M, Mohammad Ali H (2008) Gonadotropins in infertile men with idiopathic hypogonadotropic hypogonadism. Int J Fertility Steril 2:113–114

    Google Scholar 

  6. Kirk JM, Savage MO, Grant DB, Bouloux PM, Besser GM (1994) Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism. Clin Endocrinol 41:57–63

    Article  CAS  Google Scholar 

  7. Kliesch S, Behre HM, Nieschlag E (1994) High efficacy of gonadotropin or pulsatile gonadotropin-releasing hormone treatment in hypogonadotropic hypogonadal men. Eur J Endocrinol 131:347–354

    Article  PubMed  CAS  Google Scholar 

  8. McLachian RI (2000) The endocrine control of spermatogenesis. Baillieres Clin Endocrinol Metab 14:345–362

    Article  Google Scholar 

  9. Burgue′s S, Caldero′n MD, The Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism (1997) Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Hum Reprod 12:980–986

    Article  Google Scholar 

  10. Ma Y, Zhang X (2010) Hormonal treatment of male idiopathic/isolated hypogonadotropic hypogonadism. J Reprod Contracept 21:179–189

    Article  Google Scholar 

  11. Liu L, Banks SM, Barnes KM, Sherins RJ (1988) Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab 67:1140–1145

    Article  PubMed  CAS  Google Scholar 

  12. Depenbush M, von Eckardstein S, Simoni M et al (2002) Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone. Eur J Endocrinol 147:617–624

    Article  Google Scholar 

  13. Mastrogiacomo I, Motta RG, Bonanni G, Ziliotto D (1990) Treatment of male hypogonadotropic hypogonadism. Minerva Endocrinol 15(1):61–72

    PubMed  CAS  Google Scholar 

  14. El Shennawy A, Gates RJ, Russell LD (1998) Hormonal regulation of spermatogenesis in the hypophysectomized rat: cell viability after hormonal replacement in adults after intermediate periods of hypophysectomy. J Androl 19:320–334

    PubMed  CAS  Google Scholar 

  15. Saito K, O’Donnell L, McLachlan RI, Robertson DM (2000) Spermiation failure is a major contributor to early spermatogenic suppression caused by hormone withdrawal in adult rats. Endocrinology 141:2779–2785

    Article  PubMed  CAS  Google Scholar 

  16. Schopohl J, Mehltretter G, von Zumbusch R, Eversmann T, von Werder K (1991) Comparison of gonadotropin-releasing hormone and gonadotropin therapy in male patients with idiopathic hypothalamic hypogonadism. Fertil Steril 56:1143–1150

    PubMed  CAS  Google Scholar 

  17. Schopohl J (1993) Pulsatile gonadotrophin releasing hormone versus gonadotrophin treatment of hypothalamic hypogonadism in males. Hum Reprod 8:175–179

    PubMed  CAS  Google Scholar 

  18. Kliesch S, Behre HM, Nieschlag E (1994) High efficacy of gonadotropin or pulsatile gonadotropin-releasing hormone treatment in hypogonadotropic hypogonadal men. Eur J Endocrinol 131:347–354

    Article  PubMed  CAS  Google Scholar 

  19. Büchter D, Behre HM, Kliesch S et al (1998) Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol 139:298–303

    Article  PubMed  Google Scholar 

  20. van de Delemarre Waal HA (2004) Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism: diagnostic and therapeutic aspects. Eur J Endocrinol 151:U89–U94

    Article  Google Scholar 

  21. Degros V, Cortet-Rudelli C, Soudanl B, Dewailly D (2003) The human chorionic gonadotropin test is more powerful than the gonadotropin-releasing hormone agonist test to discriminate male isolated hypogonadotropic hypogonadism from constitutional delayed puberty. Eur J Endocrinol 149:23–29

    Article  PubMed  CAS  Google Scholar 

  22. Sedlmeyer IL, Palmert MR (2002) Delayed puberty: analysis of a large case series from an academic center. J Clin Endocrinol Metab 87(4):1613–1620

    Article  PubMed  CAS  Google Scholar 

  23. Fahmy I, Kamal A, Shamloul R, Mansour R, Serour G, Aboulghar M (2004) ICSI using testicular sperm in male hypogonadotrophic hypogonadism unresponsive to gonadotrophin therapy. Hum Reprod 19:1558–1561

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

To the editors and reviewers for the comments and suggestions, which were of great help in improving the quality of our report.

Author information

Authors and Affiliations

  1. Department of Urology, West China Hospital of Sichuan University, 37#Guoxuexiang street, Chengdu, 610041, Sichuan, China

    Luo Yang, Si Xiao Zhang, Qiang Dong, Zi Bing Xiong & Xiang Li

Authors
  1. Luo Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Si Xiao Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qiang Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zi Bing Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiang Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, L., Zhang, S.X., Dong, Q. et al. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience. Int Urol Nephrol 44, 393–399 (2012). https://doi.org/10.1007/s11255-011-0065-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-011-0065-0

Keywords

Search

Navigation